Assesment of Retinal Nerve Fiber Layer in First Episode Depressive Patients Using Selective Serotonin Reuptake Inhibitor

Rapid Antidepressant Effects of Ketamine in Major Depression

NCT00088699 ·Status: COMPLETED ·Phase: PHASE1/PHASE2

Repeated Neurocognitive Measurements in Depressed Patients

NCT04916548 ·Status: COMPLETED ·Phase: PHASE1/PHASE2

NMDA Modulation in Antidepressant Nonresponders With Major Depressive Disorder

NCT05136755 ·Status: RECRUITING ·Phase: PHASE2

Personalized Indicators for Predicting Response to SSRI Treatment in Major Depression (The PRISE-MD Study)

NCT00917059 ·Status: COMPLETED ·Phase: PHASE4

Efficacy and Safety of SR58611A co-Administered With Escitalopram in Adults With Major Depressive Disorder

NCT00432614 ·Status: COMPLETED ·Phase: PHASE3

Study of Antidepressant Efficacy of a Selective, High Affinity Enkephalinergic Agonist in Anxious Major Depressive Disorder (AMDD)

NCT00759395 ·Status: COMPLETED ·Phase: PHASE2

Antidepressant Effects of the Glycine Receptor Antagonist AV-101 (4-chlorokynurenine) in Major Depressive Disorder

NCT02484456 ·Status: COMPLETED ·Phase: PHASE2

Positron Emission Tomography Assessment of Ketamine Binding of the Serotonin Transporter

NCT02717052 ·Status: UNKNOWN ·Phase: PHASE2

A Study in Participants With Major Depressive Disorder (MDD) With Anhedonia and Inadequate Response to Current Antidepressant Therapy Including a Selective Serotonin Reuptake Inhibitor (SSRI) or Serotonin Norepinephrine Reuptake Inhibitor (SNRI)

NCT05841030 ·Status: COMPLETED

Effects of Antidepressant on Postsynaptic Signal Transduction in Serotonergic System of Depressed Patients

NCT01352572 ·Status: UNKNOWN ·Phase: NA

Enhancement of Learning Associated Neural Plasticity by Selective Serotonin Reuptake Inhibitors

NCT02753738 ·Status: UNKNOWN ·Phase: PHASE4

Long Term Treatment of Patients With Major Depressive Disorder With MK0869 (0869-065)(COMPLETED)

NCT00048594 ·Status: COMPLETED ·Phase: PHASE3

Study to Assess the Efficacy and Safety of NBI-1065845 in Adults With Major Depressive Disorder (MDD)

NCT05203341 ·Status: COMPLETED ·Phase: PHASE2

Emotional and Cognitive Control in Late-Onset Depression

NCT01728194 ·Status: COMPLETED ·Phase: PHASE4

Neuroimaging Study of Bupropion Treatment in Patients With Major Depressive Disorder

NCT01541475 ·Status: COMPLETED ·Phase: PHASE4

Study of Brain Response to Emotional Pictures Using a Magnetic Resonance Imaging (fMRI) While on Escitalopram

NCT00707863 ·Status: COMPLETED ·Phase: PHASE4

First Study in Humans With GSK424887

NCT01059591 ·Status: COMPLETED ·Phase: PHASE1

Brain Network Dynamics of Depression During Esketamine Treatment

NCT06012916 ·Status: COMPLETED

Neuropharmacologic Imaging and Biomarker Assessments of Response to Acute and Repeated-Dosed Ketamine Infusions in Major Depressive Disorder

NCT03065335 ·Status: RECRUITING ·Phase: PHASE1

Investigation of Antidepressant Efficacy of Oral Ketamine Treatment

NCT02992496 ·Status: UNKNOWN ·Phase: PHASE2

Pilot Study: Establishing Glutamatergic Changes in Rapid Antidepressant Effects of Ketamine

NCT06788249 ·Status: RECRUITING ·Phase: EARLY_PHASE1

Dichotic Listening as a Predictor of Medication Response in Depression

NCT00404755 ·Status: COMPLETED ·Phase: PHASE4

Study of Escitalopram in Adult Patients With Major Depressive Disorder

NCT00108979 ·Status: COMPLETED ·Phase: PHASE3

Treatment for Cognitive Impairment in Depression

NCT04317001 ·Status: WITHDRAWN ·Phase: PHASE3

A Study To Evaluate The Safety, Tolerability And Pharmacokinetics of HS-10345 In Treatment-Resistant Depression

NCT05196971 ·Status: COMPLETED ·Phase: PHASE1